A phase 1 study of CH505NP for the treatment of HIV Infection
Latest Information Update: 12 Nov 2021
Price :
$35 *
At a glance
- Drugs CH 505 NP (Primary)
- Indications HIV infections
- Focus Adverse reactions
- 12 Nov 2021 New trial record
Latest Information Update: 12 Nov 2021